Maven wins Amazon fertility account
Maven Clinic at $268M ARR
Amazon moving fertility benefits from Progyny to Maven shows that the next large employer winner is not just the company with the best IVF network, it is the one that can run a broader family health benefit across a global workforce. Maven already served Amazon employees in 50 countries for fertility and family building support, and now the relationship appears to have expanded from support and navigation into full benefits administration starting in 2025.
-
Progyny had been Amazon’s U.S. fertility benefit since 2019 and said in late 2024 that it had lost a large client for 2025. Amazon’s own Progyny member page later stated that fertility and family building benefits would transition to a different provider in 2025, with post 2024 adoption claims going to Maven.
-
The product difference is concrete. Progyny is strongest when an employer wants a managed U.S. fertility benefit centered on IVF episodes, pharmacy, and a curated clinic network. Maven sells that, but also layers on virtual care, coaching, maternity, pediatrics, and menopause in 175 countries through an asset light provider network.
-
That matters most for a company like Amazon. Amazon has about 1.5M employees globally, and Maven had already announced Amazon coverage in 50 countries in 2023. Winning the full fertility benefit means Maven can use one employer relationship to pull more members into adjacent programs over time, which is why this account is strategically larger than the direct revenue alone.
Going forward, fertility benefits will look less like a single point solution and more like the front door to family health. Maven is positioned to keep taking share with multinationals that want one vendor across countries and life stages, while Progyny remains strongest where employers prioritize deep U.S. fertility specialization over global breadth.